Thalassaemia treatment gets EU approval
New data from Parkinson’s disease trial
Restoring the “longevity protein”
Positive topline results from phase 2 recurrent ovarian cancer trial
SanegeneBio announces collaboration with Lilly
Amgen reveals cardiovascular drug results
Pila Pharma’s capital raise oversubscribed by 293% to fund obesity studies
Base to Base biotech podcast 34: World Immunization Day and infertility
Lilly investing $1.2bn in Puerto Rico facility
Launch of major diabetes fundraiser
The future of in vivo cell engineering?
AI-designed alopecia drug completes US phase I trial